| Ilomastat | IC50 | 5.2 [1] |
| (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | IC50 | 23.0 [1] |
| Batimastat | IC50 | 2.9 [1], 3.0 [2], 4.6 [3], 47.0 [4] |
| 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | IC50 | 1.1 [1], 14.0 [2] |
| N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-Carboxamide | IC50 | 10000.0 [1] |
| N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide | IC50 | 833.0 [1], 2300.0 [2] |
| CID 10370504 | IC50 | 1900.0 [1] |
| 4-[(4-But-2-ynoxyphenyl)sulfonylmethyl]-N-hydroxy-1-propan-2-ylsulfonylpiperidine-4-carboxamide | IC50 | 3642.0 [1], 4710.0 [2] |
| N-Hydroxy-4-(4-phenylsulfanylphenyl)sulfonyl-1-prop-2-ynylpiperidine-4-carboxamide | IC50 | 8.0 [1], 19.0 [2], 19.1 [3] |
| (2R,3R)-1-[4-[(2-Chloro-4-fluorophenyl)methoxy]phenyl]sulfonyl-N,3-dihydroxy-3-methylpiperidine-2-carboxamide | IC50 | 83.0 [1], 150.0 [2] |
| Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate | IC50 | 30000.0 [1], 100000.0 [2] |
| Marimastat | IC50 | 1.82 [1], 10000.0 [2] |
| 2-((4-Phenoxyphenylsulfonyl)methyl)thiirane | Ki | 37.0 [1], 110.0 [2] |
| Unii-Q56UE7E40Y | IC50 | 772.0 [1] |
| (R)-5-(6-Cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamide | IC50 | 10000.0 [1] |
| (R)-N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide | IC50 | 9.8 [1] |
| CID 6914621 | Ki | 15872.0 [1] |
| (3R)-3-[[(2S)-1-[[(1S)-2-Methoxy-1-phenylethyl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl]-6-(3-methyl-4-phenylphenyl)hexanoic acid | IC50 | 66900.0 [1] |
| N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamide | IC50 | 13.0 [1] |
| N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamide | Ki | 14.0 [1] |
| 4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic Acid | IC50 | 30000.0 [1] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamide | Ki | 10000.0 [1] |
| 2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | IC50 | 70.0 [1] |
| 2-Benzenesulfonylamino-N-[5-(4-fluoro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 330.0 [1], 390.0 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-bromo-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 180.0 [1], 200.0 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-chloro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 100.0 [1], 210.0 [2] |
| (8S,11R,12S)-12-N-Hydroxy-8-N-(2-morpholin-4-yl-2-oxoethyl)-2,10-dioxo-11-[[4-[2-(trifluoromethyl)phenyl]phenyl]methyl]-1-oxa-3,9-diazacyclopentadecane-8,12-dicarboxamide | Ki | 2000.0 [1] |
| (2S)-2-[[4-[4-[(5-Bromo-4-methoxy-3-methyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 15000.0 [1], 15135.61 [2] |
| N-(4-(4-(Thiiran-2-ylmethylsulfonyl)phenoxy)phenyl)acetamide | Ki | 680.0 [1] |
| 4-(4-(Thiiran-2-ylmethylsulfonyl)phenoxy)phenyl methanesulfonate | Ki | 145.0 [1], 150.0 [2] |
| N-Hydroxy-2-[2-methylpropyl-(4-phenylphenyl)sulfonylamino]acetamide | IC50 | 530.0 [1] |
| N-[4-[2-(Hydroxyamino)-2-oxoethyl]oxan-4-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | Ki | 5290.0 [1] |
| 2-Benzenesulfonylamino-N-[5-(5-chloro-thiophen-2-yl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 200.0 [1], 320.0 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-trifluoromethyl-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 390.0 [1], 580.0 [2] |
| 2-Benzenesulfonylamino-N-(5-p-tolyl-6H-[1,3,4]thiadiazin-2-yl)-propionamide | Ki | 150.0 [1], 290.0 [2] |
| N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)-2-benzenesulfonylamino-propionamide | Ki | 3070.0 [1] |
| (2S)-2-(Benzenesulfonamido)-N-[5-(4-cyanophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 240.0 [1], 400.0 [2] |
| (3R)-6-Cyclohexyl-N-hydroxy-3-(3-{[(methylsulfonyl)amino]-methyl}-1,2,4-oxadiazol-5-yl)hexanamide | IC50 | 100000.0 [1] |
| (3R)-6-Cyclohexyl-N-hydroxy-3-(3-{[(methylsulfonyl)amino]-methyl}-1,2,4-oxadiazol-5-yl)hexanamide | Ki | 100000.0 [1] |
| (2R)-2-(Benzenesulfonamido)-N-[5-(4-chlorophenyl)-6H-1,3,4-thiadiazin-2-yl]propanamide | Ki | 50.0 [1], 210.0 [2] |
| (2R)-2-(Benzenesulfonamido)-N-[5-(4-chlorophenyl)-6H-1,3,4-thiadiazin-2-yl]-3-methylbutanamide | Ki | 330.0 [1], 590.0 [2] |
| {(S)-4-[(Biphenyl-4-sulfonyl)-isopropoxy-amino]-4-hydroxycarbamoyl-butyl}-carbamic acid benzyl ester | IC50 | 7.7 [1] |
| (2S)-2-[[4-[4-[(5-Ethyl-4-hydroxy-3-methyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 15800.0 [1], 15848.93 [2] |
| (2S)-2-[[4-[4-[(5-Chloro-3-methyl-4-propan-2-yloxy-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 50000.0 [1], 50118.72 [2] |
| (2S)-2-[[4-[4-[(5-Iodo-4-methoxy-3-methyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 30000.0 [1], 30199.52 [2] |
| 4-[2-[[6-Fluoro-2-[(3-methoxyphenyl)methylcarbamoyl]-4-oxo-3H-quinazolin-5-yl]oxy]ethyl]benzoic acid | IC50 | 10000.0 [1] |
| 3-[2-[(E)-(4-Oxo-1,3-thiazolidin-2-ylidene)methyl]-4-pyridin-2-yl-1,3-thiazol-5-yl]propanoic acid | IC50 | 24000.0 [1] |
| N-[(1R)-1-Cyclohexyl-2-(methylamino)-2-oxoethyl]-5-[3-fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| N-[(1S)-1-Cyclohexyl-2-(methylamino)-2-oxoethyl]-5-[3-fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2S)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2R)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| 4-((4-(But-2-ynyloxy)phenylsulfonyl)methyl)-N-hydroxy-1-(pyridin-4-ylmethyl)piperidine-4-carboxamide | IC50 | 784.0 [1] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]methyl]benzoyl]amino]oxane-3-carboxamide | Ki | 5290.0 [1] |
| 5-(2-Amino-2-oxoethyl)-4-oxo-N-[(3-oxo-4H-1,4-benzoxazin-6-yl)methyl]-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidine-2-carboxamide | IC50 | 2500.0 [1], 10000.0 [2] |
| [2-[[1-Amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]-5-phenylpentyl]-[2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphinic acid | Ki | 105.0 [1] |
| (2S)-2-[[4-[4-[(5-Chloro-4-methoxy-3-methyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 12302.69 [1], 12400.0 [2] |
| (2S)-2-[[4-[4-[(4-Methoxy-3,5-dimethyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 15000.0 [1], 15135.61 [2] |
| (2S)-2-[[4-[4-[(5-Ethyl-4-methoxy-3-methyl-1-benzofuran-2-carbonyl)amino]phenyl]phenyl]sulfonylamino]-3-methylbutanoic acid | IC50 | 30000.0 [1], 30199.52 [2] |
| 4-[(4-But-2-ynoxyphenyl)sulfonylmethyl]-N-hydroxy-1-(pyridine-4-carbonyl)piperidine-4-carboxamide | IC50 | 553.0 [1], 583.0 [2] |
| Isobutyl 3-((4-(but-2-ynyloxy)phenylsulfonyl)methyl)-3-(hydroxycarbamoyl)piperidine-1-carboxylate | IC50 | 3410.0 [1] |
| N-Hydroxy-2-[2-[4-(4-methoxyphenyl)phenyl]sulfonylphenyl]acetamide | IC50 | 710.0 [1] |
| (6S,7S)-N-Hydroxy-5-methyl-6-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbonyl]-5-azaspiro[2.5]octane-7-carboxamide | IC50 | 5000.0 [1] |
| (6S,7S)-N-Hydroxy-5-methyl-6-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carbonyl]-5-azaspiro[2.5]octane-7-carboxamide | Ki | 67.6 [1] |
| (2R,3R)-4-[(2R)-2-(3-Chlorophenyl)pyrrolidin-1-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide | Ki | 1100.0 [1], 1148.0 [2] |
| N-Hydroxy-2-[(4-phenylmethoxyphenyl)sulfonylamino]acetamide | IC50 | 310.0 [1] |
| Benzyl N-[(4R)-4-[[4-[(3,5-dibromophenyl)methoxy]phenyl]sulfonylamino]-5-(hydroxyamino)-5-oxopentyl]carbamate | IC50 | 68000.0 [1] |
| 2-Benzenesulfonylamino-N-[5-(4-cyano-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-propionamide | Ki | 240.0 [1], 400.0 [2] |
| MMP3 inhibitor 1 | IC50 | 20100.0 [1] |
| N-[5-(4-Chloro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-2-phenylmethanesulfonylamino-propionamide | Ki | 180.0 [1], 190.0 [2] |
| 2-Benzenesulfonylamino-N-[5-(4-chloro-phenyl)-6H-[1,3,4]thiadiazin-2-yl]-2-methyl-propionamide | Ki | 110.0 [1], 150.0 [2] |
| (2R)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2-[[4-(trifluoromethyl)phenyl]methyl]butanamide | IC50 | 7990.0 [1], 8000.0 [2] |
| N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2,2-dimethyl-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 14870.0 [1], 15000.0 [2] |
| (2S)-2-Cyclopropyl-N-[[(4R)-4-cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 50000.0 [1], 50200.0 [2] |
| (2S)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-3-methyl-2-[[4-(trifluoromethyl)phenyl]methyl]butanamide | IC50 | 100000.0 [1] |
| (2R)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2-methyl-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 3890.0 [1], 3900.0 [2] |
| (-)-Epigallocatechin gallate | IC50 | 6800.0 [1] |
| Zoledronic acid | IC50 | 12600.0 [1] |
| Tiludronic Acid | IC50 | 30500.0 [1] |
| Prinomastat | IC50 | 0.3 [1] |
| N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide | IC50 | 88.0 [1] |
| (R)-N1-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-2-isobutylsuccinamide | IC50 | 1.9 [1] |
| N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid | IC50 | 13.0 [1] |
| (2S,3R)-N-Hydroxy-2-methyl-N'-[(1S)-2-(methylamino)-2-oxo-1-phenylethyl]-3-(2-methylpropyl)butanediamide | IC50 | 56.0 [1] |
| (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid | IC50 | 240.0 [1] |
| Epigallocatechin 3-O-(3-O-methyl)gallate | IC50 | 1700.0 [1] |
| Cipemastat | IC50 | 23.0 [1] |
| CID 9847838 | IC50 | 499.0 [1] |
| (2S,3R)-N-Hydroxy-2-methyl-N'-[(2S)-1-(methylamino)-1-oxo-3-(5,6,7,8-tetrahydronaphthalen-1-yl)propan-2-yl]-3-(2-methylpropyl)butanediamide | IC50 | 2.08 [1] |
| (Biphenyl-3-ylamino)methylenediphosphonic acid | IC50 | 40000.0 [1] |
| N-Hydroxy-N~2~-[(4-Methoxyphenyl)sulfonyl]glycinamide | IC50 | 210.0 [1] |
| [(2,4-Dichloroanilino)-phosphono-methyl]phosphonic acid | IC50 | 100000.0 [1] |
| (3-Bromophenylamino)Methylenediphosphonic Acid | IC50 | 100000.0 [1] |
| [(4-Phenylanilino)-phosphono-methyl]phosphonic acid | IC50 | 33500.0 [1] |
| [(3-Nitroanilino)-phosphono-methyl]phosphonic acid | IC50 | 100000.0 [1] |
| 4-(4-Methylphenoxy)-N-(4-pyridinylmethyl)benzenecarboxamide | IC50 | 100000.0 [1] |
| 6-(3,5-Difluoroanilino)-9-(2,2-difluoroethyl)purine-2-carbonitrile | IC50 | 426579.52 [1] |
| Grassystatin A | IC50 | 5000.0 [1] |
| (4S)-5-Amino-4-[[(2S)-2-[[(2S)-2-[[(4-bromophenyl)-hydroxyphosphoryl]methyl]-3-[3-[4-(3-chlorophenyl)phenyl]-1,2-oxazol-5-yl]propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoic acid | Ki | 140.0 [1] |
| N-Phenyl-4-[(4h-1,2,4-Triazol-3-Ylsulfanyl)methyl]-1,3-Thiazol-2-Amine | IC50 | 7500.0 [1] |
| Cruzain-IN-1 | IC50 | 72443.6 [1] |